LY3556050
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for LY3556050, covering 2023-11-02 to 2026-07-30. Get the full timeline:
Most recent: Clinical Trial Results: A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain [Phase 2]